Alzheimers Disease Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins); Distribution Channel (Hospital Pharmacies, Retail, Online Sales)

Report Code: TIPRE00015799 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Alzheimers disease (AD) is the most common reason for progressive dementia in the elderly population. It is a progressive disease that destroys memory and other critical mental functions. In the disorders, the brain cell connections and the cells themselves degenerate and die, eventually destroying memory and other essential cognitive functions. Thus, there is an increase in the demand for Alzheimers therapeutics and diagnostics worldwide.

MARKET DYNAMICS

Alzheimers disease treatment market is driving due to the increased prevalence of chronic diseases like dementia, growing demand for personalized drugs and affordable diagnostics tests, and the growing vulnerable aging population. However, the high cost for prospective medicines is hampering the Alzheimers disease treatment market's growth. Moreover, increasing research activities on Alzheimers disease treatment diagnosis and treatment is expected to provide opportunities in the global Alzheimers disease treatment market.

MARKET SCOPE

The "Alzheimers Disease Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Alzheimers disease treatment market with detailed market segmentation by drug class and distribution channel. The Alzheimers disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Alzheimers disease treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Alzheimers disease treatment market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as cholinergic, memantine, combined drug, AChE inhibitors, and immunoglobulins. Based on distribution channel, the market is segmented as hospital pharmacies, retail, and online sales.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Alzheimers disease treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Alzheimers disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Alzheimers disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Alzheimers disease treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Alzheimers disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Alzheimers disease treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Alzheimers disease treatment in the global market. Below mentioned is the list of few companies engaged in the Alzheimers disease treatment market.

The report also includes the profiles of key players in Alzheimers disease treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Allergan
  •   H. Lundbeck
  •   Teva Pharmaceutical Industries
  •   Novartis
  •   Eli Lilly
  •   Pfizer
  •   Amgen
  •   F. Hoffmann-La Roche
  •   Johnson & Johnson
  •   Daiichi Sankyo

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alzheimers Disease Treatment Market - By Drug Class
1.3.2 Alzheimers Disease Treatment Market - By Distribution Channel
1.3.3 Alzheimers Disease Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALZHEIMER'S DISEASE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALZHEIMER'S DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALZHEIMER'S DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. ALZHEIMER'S DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ALZHEIMER'S DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ALZHEIMER'S DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. CHOLINERGIC
7.3.1. Overview
7.3.2. Cholinergic Market Forecast and Analysis
7.4. MEMANTINE
7.4.1. Overview
7.4.2. Memantine Market Forecast and Analysis
7.5. COMBINED DRUG
7.5.1. Overview
7.5.2. Combined Drug Market Forecast and Analysis
7.6. ACHE INHIBITORS
7.6.1. Overview
7.6.2. AChE inhibitors Market Forecast and Analysis
7.7. IMMUNOGLOBULINS
7.7.1. Overview
7.7.2. Immunoglobulins Market Forecast and Analysis
8. ALZHEIMER'S DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL
8.4.1. Overview
8.4.2. Retail Market Forecast and Analysis
8.5. ONLINE SALES
8.5.1. Overview
8.5.2. Online Sales Market Forecast and Analysis
9. ALZHEIMER'S DISEASE TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Alzheimers Disease Treatment Market Overview
9.1.2 North America Alzheimers Disease Treatment Market Forecasts and Analysis
9.1.3 North America Alzheimers Disease Treatment Market Forecasts and Analysis - By Drug Class
9.1.4 North America Alzheimers Disease Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Alzheimers Disease Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Alzheimers Disease Treatment Market
9.1.5.1.1 United States Alzheimers Disease Treatment Market by Drug Class
9.1.5.1.2 United States Alzheimers Disease Treatment Market by Distribution Channel
9.1.5.2 Canada Alzheimers Disease Treatment Market
9.1.5.2.1 Canada Alzheimers Disease Treatment Market by Drug Class
9.1.5.2.2 Canada Alzheimers Disease Treatment Market by Distribution Channel
9.1.5.3 Mexico Alzheimers Disease Treatment Market
9.1.5.3.1 Mexico Alzheimers Disease Treatment Market by Drug Class
9.1.5.3.2 Mexico Alzheimers Disease Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Alzheimers Disease Treatment Market Overview
9.2.2 Europe Alzheimers Disease Treatment Market Forecasts and Analysis
9.2.3 Europe Alzheimers Disease Treatment Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Alzheimers Disease Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Alzheimers Disease Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Alzheimers Disease Treatment Market
9.2.5.1.1 Germany Alzheimers Disease Treatment Market by Drug Class
9.2.5.1.2 Germany Alzheimers Disease Treatment Market by Distribution Channel
9.2.5.2 France Alzheimers Disease Treatment Market
9.2.5.2.1 France Alzheimers Disease Treatment Market by Drug Class
9.2.5.2.2 France Alzheimers Disease Treatment Market by Distribution Channel
9.2.5.3 Italy Alzheimers Disease Treatment Market
9.2.5.3.1 Italy Alzheimers Disease Treatment Market by Drug Class
9.2.5.3.2 Italy Alzheimers Disease Treatment Market by Distribution Channel
9.2.5.4 Spain Alzheimers Disease Treatment Market
9.2.5.4.1 Spain Alzheimers Disease Treatment Market by Drug Class
9.2.5.4.2 Spain Alzheimers Disease Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Alzheimers Disease Treatment Market
9.2.5.5.1 United Kingdom Alzheimers Disease Treatment Market by Drug Class
9.2.5.5.2 United Kingdom Alzheimers Disease Treatment Market by Distribution Channel
9.2.5.6 Rest of Europe Alzheimers Disease Treatment Market
9.2.5.6.1 Rest of Europe Alzheimers Disease Treatment Market by Drug Class
9.2.5.6.2 Rest of Europe Alzheimers Disease Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Alzheimers Disease Treatment Market Overview
9.3.2 Asia-Pacific Alzheimers Disease Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Alzheimers Disease Treatment Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Alzheimers Disease Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Alzheimers Disease Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Alzheimers Disease Treatment Market
9.3.5.1.1 Australia Alzheimers Disease Treatment Market by Drug Class
9.3.5.1.2 Australia Alzheimers Disease Treatment Market by Distribution Channel
9.3.5.2 China Alzheimers Disease Treatment Market
9.3.5.2.1 China Alzheimers Disease Treatment Market by Drug Class
9.3.5.2.2 China Alzheimers Disease Treatment Market by Distribution Channel
9.3.5.3 India Alzheimers Disease Treatment Market
9.3.5.3.1 India Alzheimers Disease Treatment Market by Drug Class
9.3.5.3.2 India Alzheimers Disease Treatment Market by Distribution Channel
9.3.5.4 Japan Alzheimers Disease Treatment Market
9.3.5.4.1 Japan Alzheimers Disease Treatment Market by Drug Class
9.3.5.4.2 Japan Alzheimers Disease Treatment Market by Distribution Channel
9.3.5.5 South Korea Alzheimers Disease Treatment Market
9.3.5.5.1 South Korea Alzheimers Disease Treatment Market by Drug Class
9.3.5.5.2 South Korea Alzheimers Disease Treatment Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Alzheimers Disease Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Alzheimers Disease Treatment Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Alzheimers Disease Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Alzheimers Disease Treatment Market Overview
9.4.2 Middle East and Africa Alzheimers Disease Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Alzheimers Disease Treatment Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Alzheimers Disease Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Alzheimers Disease Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Alzheimers Disease Treatment Market
9.4.5.1.1 South Africa Alzheimers Disease Treatment Market by Drug Class
9.4.5.1.2 South Africa Alzheimers Disease Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Alzheimers Disease Treatment Market
9.4.5.2.1 Saudi Arabia Alzheimers Disease Treatment Market by Drug Class
9.4.5.2.2 Saudi Arabia Alzheimers Disease Treatment Market by Distribution Channel
9.4.5.3 U.A.E Alzheimers Disease Treatment Market
9.4.5.3.1 U.A.E Alzheimers Disease Treatment Market by Drug Class
9.4.5.3.2 U.A.E Alzheimers Disease Treatment Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Alzheimers Disease Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Alzheimers Disease Treatment Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Alzheimers Disease Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Alzheimers Disease Treatment Market Overview
9.5.2 South and Central America Alzheimers Disease Treatment Market Forecasts and Analysis
9.5.3 South and Central America Alzheimers Disease Treatment Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Alzheimers Disease Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Alzheimers Disease Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Alzheimers Disease Treatment Market
9.5.5.1.1 Brazil Alzheimers Disease Treatment Market by Drug Class
9.5.5.1.2 Brazil Alzheimers Disease Treatment Market by Distribution Channel
9.5.5.2 Argentina Alzheimers Disease Treatment Market
9.5.5.2.1 Argentina Alzheimers Disease Treatment Market by Drug Class
9.5.5.2.2 Argentina Alzheimers Disease Treatment Market by Distribution Channel
9.5.5.3 Rest of South and Central America Alzheimers Disease Treatment Market
9.5.5.3.1 Rest of South and Central America Alzheimers Disease Treatment Market by Drug Class
9.5.5.3.2 Rest of South and Central America Alzheimers Disease Treatment Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ALZHEIMER'S DISEASE TREATMENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALZHEIMER'S DISEASE TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ALLERGAN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. H. LUNDBECK
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TEVA PHARMACEUTICAL INDUSTRIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PFIZER
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AMGEN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. F. HOFFMANN-LA ROCHE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. JOHNSON AND JOHNSON
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DAIICHI SANKYO
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Allergan
2. H. Lundbeck
3. Teva Pharmaceutical Industries
4. Novartis
5. Eli Lilly
6. Pfizer
7. Amgen
8. F. Hoffmann-La Roche
9. Johnson & Johnson
10. Daiichi Sankyo
TIPRE00015799
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking